FDA approval of pembrolizumab from KN671
Daniel Ahn
Share Talk
October 17, 2023
4 hr
Default user image
Log in Sign Up
Channels
DiscoveryCardiology
every day
COVID
every day
Dermatology
every day
Endocrinology
every dayendo22ata22
Gastroenterology
every day
Hematology
every day
Hepatology
every day
Nephrology
every dayasn24kidneywk22nkfscm22asn23
Oncology
every dayesmo22
Ophthalmology
every dayaao23dry_eye_diseasevisions2024amdarvo2024aao22arvo22aao21wio22
Primary Care
every day
Pulmonology
every day
Rheumatology
every dayacr23acr24acr22hiv
Urology
every day
Speaker
Talk's display image
FDA approval of pembrolizumab from KN671